Skip to main content
Table of Contents
Print

Can CBD Increase BDNF Levels Linked to Mood and Depression? 

Author: Dr. Clarissa Morton, PharmD

The link between CBD and BDNF is an emerging area of research with potential implications for depression  treatment. BDNF, or brain-derived neurotrophic factor, is a protein that supports the growth and survival of brain cells. Low BDNF levels have been associated with depression, while higher levels are connected to better mood regulation and resilience. 

Early studies suggest that CBD may help boost BDNF activity, contributing to improved neuroplasticity. This could partly explain why some patients report enhanced emotional stability and reduced anxiety when using CBD. However, research remains limited, and results vary between trials. 

CBD’s Influence on Brain Health 

Studies examining CBD and BDNF often focus on how cannabinoids affect brain repair and adaptability. Below are some of the main findings in this area. 

Brain-Derived Neurotrophic Factor 

Evidence shows that brain-derived neurotrophic factors play a central role in mood regulation. CBD’s potential to enhance BDNF activity suggests a pathway through which it might support depression treatment. 

Neuroplasticity 

By influencing neuroplasticity, CBD could help the brain form new connections and recover from stress-related damage. This mechanism is thought to underlie some of the antidepressant effects seen in early trials. 

CBD Mood Effects 

Reports on CBD mood effects link higher BDNF activity with reduced rumination and greater emotional flexibility. These findings remain preliminary but offer a promising direction for future research. 

In summary, the relationship between CBD and BDNF highlights a possible biological pathway for mood improvement. While more clinical trials are needed, the early data points to CBD’s role in supporting brain health alongside traditional treatments. 

For patients curious about how CBD might influence brain repair and resilience, providers like LeafEase can offer supportive consultations tailored to individual care. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Depression. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories